Literature DB >> 10978521

Cell cycle-dependent regulation of TIAP/m-survivin expression.

M Otaki1, M Hatano, K Kobayashi, T Ogasawara, T Kuriyama, T Tokuhisa.   

Abstract

TIAP, a murine homologue of human survivin, is a member of the inhibitor of apoptosis (IAP) family and is specifically expressed at G2/M phase of the cell cycle. To elucidate regulatory mechanisms of the cycle-dependent expression, we have analyzed the promoter region of TIAP/mouse survivin (m-survivin). The 5'-flanking region of the TIAP/m-survivin gene contained a TATA-less promoter, two AP2 sites, three NF-kB sites, one Sp1 site, many cell cycle-dependent elements (CDEs) and one cell cycle gene homology region (CHR). Primer extension and 5'-rapid amplification of cDNA ends identified one transcription start site at position -100 upstream of the ATG start site (+1). TIAP/m-survivin promoter-luciferase analysis identified a minimal promoter region within the most proximal -271 bp upstream of the ATG start site, and the region between -410 and -272 was critical for the enhancer activity. The combination between the CHR at -51 and the CDE at -57 is also essential for the cell cycle-dependent expression. Mutation of the CDE/CHR element and the enhancer elements may cause disordered expression of TIAP/m-survivin to affect cell survival and oncogenesis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10978521     DOI: 10.1016/s0167-4781(00)00142-1

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  18 in total

Review 1.  Function of the A-type cyclins during gametogenesis and early embryogenesis.

Authors:  Debra J Wolgemuth
Journal:  Results Probl Cell Differ       Date:  2011

2.  Constitutive nuclear factor-kappaB activity is crucial for human retinoblastoma cell viability.

Authors:  Vassiliki Poulaki; Constantine S Mitsiades; Antonia M Joussen; Alexandra Lappas; Bernd Kirchhof; Nicholas Mitsiades
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

3.  Aging brain microenvironment decreases hippocampal neurogenesis through Wnt-mediated survivin signaling.

Authors:  Carlos J Miranda; Lyndsey Braun; Yuying Jiang; Mark E Hester; Ling Zhang; Matthew Riolo; Haijuan Wang; Meghan Rao; Rachel A Altura; Brian K Kaspar
Journal:  Aging Cell       Date:  2012-04-04       Impact factor: 9.304

4.  Association between survivin -31G > C promoter polymorphism and cancer risk: a meta-analysis.

Authors:  Xiefeng Wang; Lili Huang; Yanjie Xu; Zhumei Shi; Yingyi Wang; Junxia Zhang; Xirui Wang; Lei Cao; Hui Luo; Jiawei Chen; Ning Liu; Yongmei Yin; Yongping You
Journal:  Eur J Hum Genet       Date:  2012-01-25       Impact factor: 4.246

Review 5.  Transcriptional regulation of the survivin gene.

Authors:  Romain Boidot; Frédérique Végran; Sarab Lizard-Nacol
Journal:  Mol Biol Rep       Date:  2013-11-07       Impact factor: 2.316

6.  Cell cycle-dependent expression of cIAP2 at G2/M phase contributes to survival during mitotic cell cycle arrest.

Authors:  Hyung-Seung Jin; Tae H Lee
Journal:  Biochem J       Date:  2006-10-15       Impact factor: 3.857

7.  Regulation of survivin expression through Bcr-Abl/MAPK cascade: targeting survivin overcomes imatinib resistance and increases imatinib sensitivity in imatinib-responsive CML cells.

Authors:  Bing Z Carter; Duncan H Mak; Wendy D Schober; Maria Cabreira-Hansen; Miloslav Beran; Teresa McQueen; Wenjing Chen; Michael Andreeff
Journal:  Blood       Date:  2005-10-27       Impact factor: 22.113

8.  The association between the survivin C-31G polymorphism and gastric cancer risk in a Chinese population.

Authors:  Li Yang; Huaijun Zhu; Bo Zhou; Haijuan Gu; Hongli Yan; Naping Tang; Hanzhang Dong; Qingmin Sun; Rihong Cong; Guoyu Chen; Bin Wang
Journal:  Dig Dis Sci       Date:  2008-08-21       Impact factor: 3.199

Review 9.  Radiation Resistance: A Matter of Transcription Factors.

Authors:  Chiara Galeaz; Cristina Totis; Alessandra Bisio
Journal:  Front Oncol       Date:  2021-06-01       Impact factor: 6.244

10.  MEK1/2 inhibition enhances the radiosensitivity of cancer cells by downregulating survival and growth signals mediated by EGFR ligands.

Authors:  Eun Joo Chung; Mary Ellen Urick; Naamit Kurshan; William Shield; Hiroaki Asano; Paul D Smith; Bradley S Scroggins; Jeffrey Burkeen; Deborah E Citrin
Journal:  Int J Oncol       Date:  2013-04-10       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.